Pesquisa | Portal de Pesquisa da BVS Enfermagem

1.

The presence of non-hepatic malignancy and its implication in pursuing liver transplantation.

Chayanupatkul, Maneerat; Gambarin-Gelwan, Maya; Schiano, Thomas D.

Clin Transplant ; 35(10): e14410, 2021 10.

Artigo em Inglês | MEDLINE | ID: mdl-34189778

2.

Hepatocellular carcinoma in patients with no identifiable risk factors.

McIntyre, Caitlin A; Chou, Joanne F; Gonen, Mithat; Shia, Jinru; Gambarin-Gelwan, Maya; Balachandran, Vinod P; Kingham, T Peter; Allen, Peter J; Drebin, Jeffrey A; Jarnagin, William R; D'Angelica, Michael I.

HPB (Oxford) ; 23(1): 118-126, 2021 01.

Artigo em Inglês | MEDLINE | ID: mdl-32591247

3.

Clinical implications of drug-induced liver injury in early-phase oncology clinical trials.

Mondaca, Sebastian P; Liu, Dazhi; Flynn, Jessica R; Badson, Sandy; Hamaway, Stefan; Gounder, Mrinal M; Khalil, Danny N; Drilon, Alexander E; Li, Bob T; Jhaveri, Komal L; Schram, Alison M; Kargus, Katherine E; Kasler, Mary Kate; Blauvelt, Natalie M; Segal, Neil H; Capanu, Marinela; Callahan, Margaret K; Hyman, David M; Gambarin-Gelwan, Maya; Harding, James J.

Cancer ; 126(22): 4967-4974, 2020 11 15.

Artigo em Inglês | MEDLINE | ID: mdl-32809222

4.

High prevalence of colon adenomas in end-stage kidney disease patients on hemodialysis undergoing renal transplant evaluation.

Saumoy, Monica; Jesudian, Arun B; Aden, Brandon; Serur, David; Sundararajan, Subha; Sivananthan, Geethan; Gambarin-Gelwan, Maya.

Clin Transplant ; 30(3): 256-62, 2016 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-26714740

5.

FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B.

Zeremski, Marija; Dimova, Rositsa B; Benjamin, Samantha; Makeyeva, Jessy; Yantiss, Rhonda K; Gambarin-Gelwan, Maya; Talal, Andrew H.

BMC Gastroenterol ; 14: 118, 2014 Jul 03.

Artigo em Inglês | MEDLINE | ID: mdl-24990385

6.

Resistance-associated variants in chronic hepatitis C patients treated with protease inhibitors.

Gambarin-Gelwan, Maya; Jacobson, Ira M.

Curr Gastroenterol Rep ; 14(1): 47-54, 2012 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-22161022

7.

Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.

Torres, Harrys A; Chong, Pearlie P; De Lima, Marcos; Friedman, Mark S; Giralt, Sergio; Hammond, Sarah P; Kiel, Patrick J; Masur, Henry; McDonald, George B; Wingard, John R; Gambarin-Gelwan, Maya.

Biol Blood Marrow Transplant ; 21(11): 1870-82, 2015 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-26256943

8.

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC.

Santini, Fernando C; Rizvi, Hira; Plodkowski, Andrew J; Ni, Andy; Lacouture, Mario E; Gambarin-Gelwan, Maya; Wilkins, Olivia; Panora, Elizabeth; Halpenny, Darragh F; Long, Niamh M; Kris, Mark G; Rudin, Charles M; Chaft, Jamie E; Hellmann, Matthew D.

Cancer Immunol Res ; 6(9): 1093-1099, 2018 09.

Artigo em Inglês | MEDLINE | ID: mdl-29991499

9.

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Gambarin-Gelwan, Maya; Kinkhabwala, Sanjiv V; Schiano, Thomas D; Bodian, Carol; Yeh, Hsu-Chong; Futterweit, Walter.

Clin Gastroenterol Hepatol ; 5(4): 496-501, 2007 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-17287148

10.

Hepatitis B in pregnancy.

Gambarin-Gelwan, Maya.

Clin Liver Dis ; 11(4): 945-63, x, 2007 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-17981236

11.

Chronic hepatitis C genotype 2 and 3: are we ready for personalized medicine?

Gambarin-Gelwan, Maya; Jacobson, Ira M.

J Hepatol ; 55(3): 505-506, 2011 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-21601599

12.

Cancer history and other personal factors affect quality of life in patients with hepatitis C.

Olson, Sara H; Iyer, Sandy; Scott, Jennifer; Erez, Orry; Samuel, Shelby; Markovits, Temima; Schwartz, Myron; Toro, Charlene; Gambarin-Gelwan, Maya; Kurtz, Robert C.

Health Qual Life Outcomes ; 3: 39, 2005 Jun 16.

Artigo em Inglês | MEDLINE | ID: mdl-15960844

13.

Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma.

Gambarin-Gelwan, Maya.

Chin Clin Oncol ; 2(4): 32, 2013 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-25841911

14.

Advances in the treatment of hepatitis C virus infection.

Jesudian, Arun B; Gambarin-Gelwan, Maya; Jacobson, Ira M.

Gastroenterol Hepatol (N Y) ; 8(2): 91-101, 2012 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-22485076

15.

Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.

Harris, Adam; Eswaran, Shanti; Bosworth, Brian; Gambarin-Gelwan, Maya; Scherl, Ellen J.

Gastroenterol Hepatol (N Y) ; 3(11): 875-7, 2007 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-21960800

16.

Percutaneous Liver Biopsy.

Gambarin-Gelwan, Maya.

Gastroenterol Hepatol (N Y) ; 2(9): 689-690, 2006 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-28316539

Portal de Pesquisa da BVS Enfermagem

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

The presence of non-hepatic malignancy and its implication in pursuing liver transplantation.

Hepatocellular carcinoma in patients with no identifiable risk factors.

Clinical implications of drug-induced liver injury in early-phase oncology clinical trials.

High prevalence of colon adenomas in end-stage kidney disease patients on hemodialysis undergoing renal transplant evaluation.

FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B.

Resistance-associated variants in chronic hepatitis C patients treated with protease inhibitors.

Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.

Safety and Efficacy of Re-treating with Immunotherapy after Immune-Related Adverse Events in Patients with NSCLC.

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

Hepatitis B in pregnancy.

Chronic hepatitis C genotype 2 and 3: are we ready for personalized medicine?

Cancer history and other personal factors affect quality of life in patients with hepatitis C.

Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma.

Advances in the treatment of hepatitis C virus infection.

Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.

Percutaneous Liver Biopsy.